9/19/2008

The Global Harmonization Task Force's Study Group 1 has published its final guidance for classifying in vitro diagnostic medical devices. A four-tiered, risk-based system should be specifically designed for categorizing such products, according to the guidance.

Full Story:
FDAnews

Related Summaries